Illumina Acquires Moleculo, Pre-announces Q4 Revenue Growth of 8 Percent | GenomeWeb

This article has been updated from a previous version, which had incorrectly transposed the year-over-year and sequential growth percentages for fourth-quarter revenue.

SAN FRANCISCO (GenomeWeb News) - Illumina CEO Jay Flatley today announced at the JP Morgan Healthcare Conference here that the firm has acquired long-read sequencing technology firm Moleculo for an undisclosed amount.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.